PTPN1 and colon carcinoma: In addition, the other compounds were evaluated for their cytotoxicities (against human cervical epitheloid carcinoma (HeLa), human colon carcinoma (HCT-116), and human lung epithelial carcinoma (A549) tumor cell lines) and target inhibitory activities (against protein tyrosine phosphatase 1B (PTP1B)).